These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13040333)

  • 1. The anticoagulant effect of phenylindanedione in thromboembolic disorders.
    BROWN KW; MACMILLAN RL
    Am J Med Sci; 1953 May; 225(5):495-500. PubMed ID: 13040333
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.
    CHALMERS JN; DIXON MF; POLACK W
    Br Med J; 1954 Oct; 2(4894):956-9. PubMed ID: 13199354
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the anticoagulant phenylindanedione. I. The effect of emulsified vitamin K1 on phenylindanedione-induced hypoprothrombinemia.
    GUTTAS CG; MOLONEY WC; SISE HS
    Blood; 1953 Mar; 8(3):276-81. PubMed ID: 13032197
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of phenylindanedione (danilone) in therapy of thromboembolic diseases].
    MILANES LOPEZ B; HERNANDEZ DIAZ DE ACEVEDO AL; TOLEDO VALDIVIA FB; NAVARRETTE G
    Rev Cubana Cardiol; 1954; 14(3-4):181-94. PubMed ID: 13195101
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical study of phenylindanedione (danilone) in the treatment of thromboembolic diseases.
    MILANES LOPEZ B; HERNANDEZ AL; TOLEDO VALDIVIA F; NAVARRETE G
    Angiologia; 1954; 6(5):203-16. PubMed ID: 13218328
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
    TOOHEY M
    Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of phenylindanedione in acute thromboembolic disease; observations in 35 patients.
    KIM CS
    U S Armed Forces Med J; 1954 Nov; 5(11):1623-34. PubMed ID: 13205794
    [No Abstract]   [Full Text] [Related]  

  • 9. The control of excessive effect by anticoagulants.
    DUFF IF; GAMBLE JR; WILLIS PW; HODGSON PE; WILSON WS; POLHEMUS JA
    Ann Intern Med; 1955 Nov; 43(5):955-78. PubMed ID: 13268991
    [No Abstract]   [Full Text] [Related]  

  • 10. [On long term treatment of heart infarction with anticoagulants].
    Dabels J; Konrad H; Schulz K
    Z Gesamte Inn Med; 1968 Apr; 23(7):Suppl:105-7. PubMed ID: 4973148
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of three anticoagulants in thrombo-embolic disease.
    NEILSON JM; MOLLISON AW
    Br Med J; 1957 May; 1(5029):1214-7. PubMed ID: 13426587
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial of phenylindanedione as an anticoagulant.
    TOOHEY M
    Br Med J; 1953 Mar; 1(4811):650-2. PubMed ID: 13032434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preventive anticoagulant treatment in surgery. Indications--technics].
    Nicolas F
    Anesth Analg (Paris); 1967; 24(5):497-505. PubMed ID: 5593939
    [No Abstract]   [Full Text] [Related]  

  • 15. The mode of action of phenylindanedione.
    WALKER W; HUNTER RB
    J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant therapy of thromboembolic diseases with special reference to phenindione].
    REMDE W
    Dtsch Gesundheitsw; 1953 Nov; 8(45):1371-6. PubMed ID: 13116730
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylindanedione: a useful anticoagulant.
    TOWNSEND SR; FAY KJ; DOWNING JR; LAING R; CAMERON DG
    Can Med Assoc J; 1953 Aug; 69(2):149-51. PubMed ID: 13067053
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status of use of phenylindanedione: case report.
    McCABE ES; FITTIPOLDI J
    Am Pract Dig Treat; 1953 Nov; 4(11):765-7. PubMed ID: 13104841
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with anticoagulant danilone (phenylindanedione) in 72 patients.
    PINSKY ST; PIETZ DG; WOOLLING KR; DRAKE WL
    J Indiana State Med Assoc; 1955 Oct; 48(10):1085-94. PubMed ID: 13263636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.